Anavex Life Sciences Corp (AVXL)

[Pineapple1]

Biotech Analyst gave AVXL an 18% chance of successfully treating Rett...
Yes I did state that NOBLE's PHD analyst had decided what was an achievable number, but would like to continue to expand upon his research. The data that he quoted was from Dec '16, and we have had continued success in our trials, and confirmation from Dr. Missling that our trials are designed to fail quickly. With each passing day we are building upon the likelihood of success, and with all the data that I have read, am more encouraged than an 18% chance. I would venture a guess much higher.
On another note, I contacted IR about expanded access potential for a relative of mine that has Parkinson's, and got the opportunity to discuss the company's position on Expanded/compassionate access.
The reply was that the company is focused on a methodical progression of research, and not interested in getting involved with expanded access. I told them that I was concerned with the pace that the FDA has shown in the past regarding approval, when we have a drug that has shown to be safe, and effective.
IR pointed out that the company has already achieved many milestones (if you review what they have done) and I would have to agree. They stated information will be forth coming as soon as available and reiterated that trials are still planned for 2017.